Join SolarWinds at the 2023 Gartner IT Symposium Xpo: A Global Event Not to Be Missed!

SolarWinds Showcases Product Portfolio at Gartner IT Symposium/Xpo™ 2023 AUSTIN, Texas–(BUSINESS WIRE)–SolarWinds (NYSE:SWI), a leading provider of simple, powerful, secure observability and IT management software, today announced it will participate in the Gartner IT Symposium/Xpo™ 2023 conferences held worldwide over the coming months. SolarWinds will be showcasing its product portfolio at the Gartner IT Symposium/Xpo™…

Read More

Important Shareholder Reminder: Securities Fraud Class Action Lawsuit Filed Against Hawaiian Electric Industries, Inc. by Kessler Topaz Meltzer & Check LLP

Welcome to our blog post on the securities class action lawsuit against Hawaiian Electric Industries, Inc. Introduction The law firm of Kessler Topaz Meltzer & Check, LLP recently filed a securities class action lawsuit against Hawaiian Electric Industries, Inc. The lawsuit was filed in the United States District Court for the Northern District of California….

Read More

Protect Your Investment: Important Reminder for SYNH Shareholders Regarding Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check LLP

Protect Your Investment: Important Reminder for SYNH Shareholders Regarding Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check LLP RADNOR, Pa., Sept. 10, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Syneos Health, Inc. (“Syneos”)…

Read More

Revolutionizing Business Expense Management: Zilbank’s Virtual Card Solutions

The Gift Card and Expense Card Helps Businesses with Seamless Transactions ZilBank Introduces Virtual Card for Efficient Expense Management Tyler, Texas, United States, September 10, 2023/EINPresswire.com/ — ZilBank, a leading B2B financial solution, announced the launch of Virtual Card for businesses, enabling efficient expense management. This feature allows businesses to easily issue virtual cards to…

Read More

Get Ready to Geek Out: Mineralys Therapeutics Reveals Exciting Target HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions!

Welcome to the Mineralys Therapeutics Show! Time to Talk Lorundrostat and Blood Pressure Reduction by: Your Quirky Medical Guru Hey there, fellow health enthusiasts! Today, we’re diving into the exciting world of lorundrostat, the highly selective aldosterone synthase inhibitor that is making waves in the medical community. Recently, a groundbreaking study published in the Journal…

Read More